22 results match your criteria: "St Bartholomew's and Royal London Hospitals[Affiliation]"

Editorial for: "Noncontrast MR Lymphography in Secondary Lower Limb Lymphedema".

J Magn Reson Imaging

February 2021

NIHR Nottingham Biomedical Research Centre, Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF

ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus.

Eur J Endocrinol

August 2020

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes.

View Article and Find Full Text PDF

Background: Drug choice and metabolic changes with antiretroviral therapy contribute to cardiovascular risk in persons with HIV-1 infection.

Methods: A randomized, 12 week, open-label, comparative study of the impact on lipids of continuation of abacavir/lamivudine (ABC/3TC) plus efavirenz (EFV) or replacement with the single tablet regimen of EFV/emtricitabine/tenofovir DF (EFV/FTC/TDF) in hypercholesterolaemic subjects on successful antiretroviral therapy, with a 12-week extension with all subjects on EFV/FTC/TDF.

Results: 157 subjects received study drug, 79 switched to EFV/FTC/TDF and 78 subjects continued ABC/3TC+EFV.

View Article and Find Full Text PDF

It has recently been proposed that statins act as vitamin D analogs in binding the ubiquitously expressed vitamin D receptor, accounting for the perceived pleiotropic effects of statins (a reduction in cancer risk, prevention of organ transplant rejection and autoimmune disease). Chronic kidney disease (CKD) offers a useful test of this hypothesis: serum 25-hydroxyvitamin D levels are insufficient (<75 nmol/l) in as many as 76% of patients with advanced CKD, associated with secondary hyperparathyroidism and reduced bone mineralization. Vitamin D suppresses parathyroid hormone (PTH) secretion in part through its action on the vitamin D receptor.

View Article and Find Full Text PDF

Tuberculosis and its future management.

Thorax

December 2007

Department of Respiratory Medicine, St Bartholomew's and Royal London Hospitals, London EC1A 7BE, UK.

Will we do better in the next 25 years?

View Article and Find Full Text PDF

Recent advances in the diagnosis and management of bacterial keratitis.

Int Ophthalmol Clin

September 2007

Department of Ophthalmology, St. Bartholomew's and Royal London Hospitals, University of London, London, UK.

View Article and Find Full Text PDF

We present a case of bilateral angle-closure glaucoma secondary to bilateral posterior scleritis with ciliochoroidal detachment following sequential phacoemulsification cataract extraction. To our knowledge, this is the first report of this complication.

View Article and Find Full Text PDF

Quality of surgical instruments.

Ann R Coll Surg Engl

July 2006

Department of Clinical Physics, St Bartholomew's and Royal London Hospitals, London, UK.

Introduction: Many surgeons will have encountered the scissors that would not cut, and the artery clip that comes off in a deep difficult location, but it would be reasonable to assume that new instruments should be of assured quality. This study reports the surprising findings of a local quality control exercise for new instruments supplied to a single trust.

Materials And Methods: Between January 2004 and June 2004, all batches of new surgical instruments ordered by the Central Sterile Supplies Department of St Bartholomew's and the Royal London Hospitals were assessed by three clinical engineers, with reference to British Standards (BS) requirements.

View Article and Find Full Text PDF

Collapsing glomerulopathy in adult still's disease.

Am J Kidney Dis

May 2004

Department of Renal Medicine and Transplantation, St. Bartholomew's and Royal London Hospitals, Barts and The London NHS Trust, London, United Kingdom UK.

Idiopathic collapsing glomerulopathy is a clinically and pathologically distinct variant of focal segmental glomerulosclerosis characterized clinically by a male and Afro-Caribbean racial predominance, proteinuria (often nephrotic range), and rapid progression to end-stage renal failure. Pathologically, the typical changes are global glomerular collapse leading to obliteration of glomerular capillary lumina, hypertrophy and hyperplasia of podocytes, and severe tubulointerstitial changes. A secondary form with almost identical pathologic features is described in association with human immunodeficiency virus infection.

View Article and Find Full Text PDF

VIN is thought to be the precursor of some VSCCs because it is monoclonal, frequently occurs contiguously with VSCC and shares similar risk factors with a subgroup of VSCC. There has been no conclusive molecular evidence supporting this assumption. We performed X-chromosome inactivation analysis on 9 cases of lone VIN, 10 cases of VSCC and associated contiguous VIN and 11 cases of VSCC and associated noncontiguous VIN.

View Article and Find Full Text PDF

Multidrug-resistant tuberculosis: this is the cost.

Ann N Y Acad Sci

December 2001

Department of Respiratory Medicine, St. Bartholomew's and Royal London Hospitals, United Kingdom.

The costs of multidrug-resistant tuberculosis (MDR TB) reach far beyond the cost of the clinical treatment of the patient. The first impact of the discovery of MDR TB in a population is the need to recognize that all TB patients have the potential of being MDR. Public health measures to prevent the spread of MDR TB, or to control or reverse the problem where spread has already occurred, can be extremely expensive to implement.

View Article and Find Full Text PDF

Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancer.

Urol Int

January 2002

Department of Medical Oncology, School of Medicine and Dentistry, St. Bartholomew's and Royal London Hospitals, Queen Mary and Westfield College, Smithfield, London, UK.

Purpose: This phase 1/2 study was designed to test toxicity and effectiveness of combination chemotherapy and concurrent radiotherapy in the treatment of invasive bladder cancer.

Methods And Materials: 17 patients with localised muscle-invasive bladder cancer, clinical stages T2-3 N0, M0, were treated with a radiotherapy schedule of 55 Gy in 20 fractions over 4 weeks restricted to the bladder and 3 cycles of concurrent dose-intensive combination chemotherapy consisting of cisplatin 60 mg/m(2), vincristine 2 mg and methotrexate 60 mg/m(2) at 10-day intervals (MOPq10).

Results: The complete remission rate following MOPq10 chemotherapy and radiotherapy was 88% as assessed at first cystoscopy with 82% remaining disease-free at 1 year.

View Article and Find Full Text PDF

Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?

Acta Oncol

January 2001

Department of Medical Oncology, School of Medicine & Dentistry, St Bartholomew's and Royal London Hospitals, Queen Mary & Westfield College, Smithfield, UK.

Thirty consecutive patients with relapsing germ cell tumours (GCT) were treated with induction chemotherapy and high-dose chemotherapy consolidation (HDCT). Overall, 47% were progressionfree and 53% were alive with a median follow up of 40 months. Initially, HDCT was given as consolidation of third line VIP (etoposide/ifosfamide and cisplatin), following failure of a weekly cisplatin regimen.

View Article and Find Full Text PDF

Background: High-dose chemotherapy has an established role in recurrent or refractory Hodgkin's lymphoma (HL) although a significant proportion of patients subsequently relapse. This manuscript describes the clinical characteristics of such patients and documents their further management at two major UK cancer centres.

Patients And Methods: Between 1987 and 1996 one hundred patients with recurrent or refractory HL received high-dose chemotherapy (HDCT) with autologous haematopoietic rescue.

View Article and Find Full Text PDF

Intermittent hormone therapy: its potential in early prostate cancer and intra-epithelial neoplasia.

Gan To Kagaku Ryoho

May 2000

Department of Medical Oncology, School of Dentistry and Medicine, Queen Mary and Westfield College, St Bartholomew's and Royal London Hospitals, Smithfield, London.

This paper reviews results from a pilot study of 40 patients entered on intermittent hormone therapy having achieved a PSA complete remission. The median time to clinical progression and need for further hormone therapy was 14 month; and 88% of patients retreated are progression-free at 1 year and an overall 88% are alive at 3 years. There was some evidence that there was slower progression to require treatment in older patients and those who had been on treatment for more than 15 months.

View Article and Find Full Text PDF

Recent evidence (1) suggests that the related peptides calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) bind to the same heptahelical transmembrane receptor, with receptor specificity being determined by a receptor associated modifying protein (RAMP). If correct, this hypothesis would predict that each peptide should desensitize the cellular response to subsequent stimulation by itself or the other peptide. We have therefore studied the patterns of desensitization of these receptors in SK-N-MC cells.

View Article and Find Full Text PDF